Director, Rare Disease Market Access Strategy

Biogen•Cambridge, MA

5d•$204,000 - $281,000

About The Position

The Director of Rare Disease Market Access Strategy will lead development and execution of MA&R strategy for Friedreich Ataxia (FA), including the development of payer messaging, pricing & contracting strategy, coordination across all other MA&R functions, and alignment with the Rare Disease Franchise. This role will report to the Head of Rare Disease Access Strategy within the US Market Access & Reimbursement and lead a rare disease access strategy team in optimizing access for Friedreich Ataxia (FA).

Requirements

Bachelor’s degree required, MBA preferred
10+ years of experience in U.S. market access, payer marketing, pricing, or related fields within the pharmaceutical or biotech industry
Ability to work cross-functionally to develop payer messaging, contracting strategy, build business cases, and develop training/communication plans for field teams
Knowledge of standard Payer research methodologies, financial analyses, and gross-to-net dynamics
Excellent analytical, strategic thinking and critical thinking skills with the ability to translate data into strategy
Must be highly motivated with strong interpersonal and communications skills
Ability to develop and deliver clear, compelling presentations on complex pricing topics to senior-level executive audience
Ability to handle multiple tasks and effectively prioritize to meet individual and team goals.
Must be able to produce high quality, accurate work under time constraints.
Ability to build and maintain strong cross-functional and cross-team ties to influence colleagues.
Must have the ability to work effectively in a team environment

Responsibilities

Develop and execute comprehensive market access strategies to support the FA brands across commercial and government payer segments.
Lead cross-functional planning and execution across all MA&R functions (including Payer Insights, Trade & Distribution, Patient Access, and National & Regional Account Teams) to ensure alignment with approved strategies
Ensure coordination and alignment with the Rare Disease Franchise, including on overall strategy as well as internal and external messaging.
Deliver impactful value propositions, messaging, and promotional materials (both branded and unbranded) tailored to key customer segments (e.g., plans, PBMs, GPOS, IDNs)
Champion pull-through activities to ensure access optimization
Partner with Medical, HEOR, Global V&A to support evidence generation to support access strategy
Define and drive the contracting strategy in collaboration with Brand, legal, and finance to align with market dynamics and brand goals.
Develop pricing and innovative contracting strategies (e.g., value-based contracts)
Work with cross-functional teams to model scenario-based business cases to support key contracting recommendations to senior leadership
Research, compile, analyze, and assess market landscape data/trends to develop customized solutions that maximize patient access
Support development of Free Drug and co-pay support strategies
Support development of SP and SD strategies to optimize patient access
Execute and support training of MA&R RADs and NADs in alignment with approved strategies and materials
Lead initiatives to evaluate MA&R performance in support of the Rare Disease Franchise
Lead and support multiple cross functional teams in various projects as a market access expert (e.g., gross-to-net workstreams, forecasting, long-range planning, etc.)
Support pipeline activities, including Biogen’s pipeline assets for rare disease

Benefits

Medical, Dental, Vision, & Life insurances
Fitness & Wellness programs including a fitness reimbursement
Short- and Long-Term Disability insurance
A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
Up to 12 company paid holidays + 3 paid days off for Personal Significance
80 hours of sick time per calendar year
Paid Maternity and Parental Leave benefit
401(k) program participation with company matched contributions
Employee stock purchase plan
Tuition reimbursement of up to $10,000 per calendar year
Employee Resource Groups participation